|
 |
| home > pmps > summer 2002 > filling systems for inhalant powders - trends and challenges |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
There is an increasing demand to develop new drug delivery systems in order to create a wider palette of possibilities for delivering medicaments to the patient. Of these, the inhalation of micronised powders, where a predetermined dose is inhaled into the lungs or passes over the nasal mucous membrane en route to the bloodstream is a major developing area. This article will address the challenges that face the packaging and device industry when developing systems for the new generations of micronised inhaler powder drug delivery systems.
Developers of inhalation devices, powder formulators and suppliers of powder dosing systems and inhalator assembly systems need to work together to be successful. To bring such technically demanding projects in on time and to budget requires considerable team work - not just in theory, but in practice - between the various parties.
Typically the development department of a pharmaceutical company will need to work with its regulatory and quality functions, its manufacturing operation and designers and suppliers of the various components and packaging materials. It is helpful that the machine supplier is able to provide a complete machinery package - from powder filling through to assembly - to focus on the interactions within the machinery system. A good working relationship is essential if the delivery system is to complement the pharmaceutical product.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
MipTec, October 14 – 16, 2008, Switzerland
MipTec about to take off by joining forces between Life Sciences Week, ALL-SystemsX.ch-Day, & Jobvector.com
More info >> |
|
 |
